Serum Oxidative/anti-oxidative Stress Balance Is Dysregulated in Potentially Pulmonary Hypertensive Patients with Liver Cirrhosis: A Case Control Study.

OBJECTIVE Hepatopulmonary syndrome (HPS) is characterized by vascular dilatation and hyperdynamic circulation, while portopulmonary hypertension (POPH) is characterized by vasoconstriction with fibrous obliteration of the vascular bed. Vasoactive molecules such as nitric oxide (NO) are candidate factors for cirrhotic complications associated with these diseases. However, oxidative stress balance is not well characterized in HPS and POPH. The present objective is to investigate the oxidative stress and anti-oxidative stress balance and NO pathway balance in patients with potential HPS and POPH. METHODS We recruited patients with decompensated cirrhosis (n=69) admitted to our hospital as liver transplantation candidates. Patients exhibiting partial pressure of oxygen lower than 80 mmHg and alveolar-arterial oxygen gradient (AaDO2) ≥15 mmHg were categorized as potentially having HPS (23 of 69 patients). Patients exhibiting a tricuspid regurgitation pressure gradient ≥25 mmHg were categorized as potentially having POPH (29 of 61 patients). Serum reactive oxygen metabolites were measured and anti-oxidative OXY-adsorbent test (OXY) were performed, and the balance of these tests was defined as the oxidative index. The correlation between these values and the clinical characteristics of the patients were assessed in a cross-sectional study. RESULTS Potential HPS patients exhibited no correlation with oxidative stress markers. Potential POPH patients exhibited lower OXY (p=0.037) and higher oxidative index values (p=0.001). Additionally, the vascular NO synthase enzyme inhibiting protein, asymmetric dimethylarginine, was higher in potential POPH patients (p=0.049). The potential POPH patients exhibited elevated AaDO2, suggesting the presence of pulmonary shunting. CONCLUSION Potential POPH patients exhibited elevated oxidative stress with decreased anti-oxidative function accompanied by inhibited NO production. Anti-oxidants represent a candidate treatment for potential POPH patients.

[1]  Dean P. Jones,et al.  Oxidative Stress Is Associated With Increased Pulmonary Artery Systolic Pressure in Humans , 2014, Hypertension.

[2]  D. Grekas,et al.  Elevated Asymmetric Dimethylarginine is Associated With Oxidant Stress Aggravation in Patients With Early Stage Autosomal Dominant Polycystic Kidney Disease , 2014, Kidney and Blood Pressure Research.

[3]  S. Black,et al.  Reactive oxygen species in pulmonary vascular remodeling. , 2013, Comprehensive Physiology.

[4]  Xiaoping Chen,et al.  4-HNE Increases Intracellular ADMA Levels in Cultured HUVECs: Evidence for miR-21-Dependent Mechanisms , 2013, PloS one.

[5]  K. Kuwaki,et al.  Serum oxidative–anti‐oxidative stress balance is dysregulated in patients with hepatitis C virus‐related hepatocellular carcinoma , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[6]  J. Cooke,et al.  The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis , 2013, The Journal of pathology.

[7]  A. Duarte-Rojo,et al.  Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview , 2012, European Respiratory Review.

[8]  C. Vassalle,et al.  Sex-related differences in association of oxidative stress status with coronary artery disease. , 2012, Fertility and sterility.

[9]  T. Tomofuji,et al.  Periodontal treatment decreases plasma oxidized LDL level and oxidative stress , 2011, Clinical Oral Investigations.

[10]  A. Takaki,et al.  Stage of hepatocellular carcinoma is associated with periodontitis. , 2011, Journal of clinical periodontology.

[11]  C. Verslype,et al.  Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets , 2010, Acta Pharmacologica Sinica.

[12]  N. Donos,et al.  Oxidative Stress, Systemic Inflammation, and Severe Periodontitis , 2010, Journal of dental research.

[13]  C. Hart,et al.  Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. , 2010, American journal of respiratory cell and molecular biology.

[14]  D. Dutta,et al.  The role of garlic in hepatopulmonary syndrome: a randomized controlled trial. , 2010, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[15]  T. Tomofuji,et al.  Short-term effects of non-surgical periodontal treatment on plasma level of reactive oxygen metabolites in patients with chronic periodontitis. , 2009, Journal of periodontology.

[16]  S. Nakatani,et al.  Noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. , 2009, The American journal of cardiology.

[17]  Seung-Oe Lim,et al.  Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. , 2008, Gastroenterology.

[18]  R. Wiesner,et al.  Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  V. Shah,et al.  Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. , 2008, Gastroenterology.

[20]  S. Black,et al.  Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction. , 2008, American journal of physiology. Cell physiology.

[21]  M. Torbenson,et al.  Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration , 2008, Hepatology.

[22]  K. Dickstein,et al.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.

[23]  R. Wiesner,et al.  Natural history of hepatopulmonary syndrome: Impact of liver transplantation , 2005, Hepatology.

[24]  R. Rodríguez-Roisín,et al.  Pulmonary–Hepatic vascular Disorders (PHD) , 2004, European Respiratory Journal.

[25]  C. Strassburg,et al.  Portopulmonary hypertension and hepatopulmonary syndrome , 2004, The Lancet.

[26]  C. Madl,et al.  Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. , 2003, Gastroenterology.

[27]  M. Fallon,et al.  Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation , 2003, Hepatology.

[28]  P. Vallance,et al.  S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: Further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Fox,et al.  Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins. , 2000, Genomics.

[30]  G. Abrams,et al.  Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial. , 1998, Journal of clinical gastroenterology.

[31]  C. Bucca,et al.  Exhaled Nitric Oxide and Impaired Oxygenation in Cirrhotic Patients before and after Liver Transplantation , 1998, Annals of Internal Medicine.

[32]  E. Dickson,et al.  Hepatopulmonary Syndrome: Clinical Observations and Lack of Therapeutic Response To Somatostatin Analogue , 1993 .

[33]  Hidetoshi Sato,et al.  Myocardial injury in patients with chronic hepatitis C infection. , 2013, Journal of hepatology.